Fund moves

Roivant Sciences (ROIV): Weiss Asset Management LP opened a new position $90M

Weiss Asset Management LP opened a new position in Roivant Sciences, per its Q2 2026 13F.

2.54M
Shares reported
1.2%
Disclosed portfolio weight
$90M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 14, 2026

What stands out in this filing

  • A new position in Q2 2026: 2,542,652 shares, none in the manager's Q1 2026 filing.
  • Reported at $90M, 1.20% of the portfolio value in this 13F filing.
  • 13 other tracked managers reported the same kind of change for Q2 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 24, 2026Insider · 1 personInsiders: 2 sales (~$6.6M)
  2. Jun 25, 2026InsiderDirector sold ~$17.1M of ROIV shares in the open market
  3. Jun 26, 2026Insider · 4 peopleInsiders: 7 sales (~$80.9M)
  4. Jun 29, 2026Insider · 4 peopleInsiders: 8 sales (~$83.5M)
  5. Jun 30, 2026Insider · 4 peopleInsiders: 5 sales (~$8.7M)
  6. Jul 27, 2026InsiderCEO sold ~$6.99M of ROIV shares in the open market
  7. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  8. Aug 14, 2026InsiderDirector sold ~$8.81M of ROIV shares in the open market

What came next

  1. Aug 17, 2026InsiderDirector sold ~$10.3M of ROIV shares in the open market
  2. Aug 18, 2026Insider · 1 personInsiders: 2 sales (~$5.0M)
  3. Aug 19, 2026InsiderDirector sold ~$6.43M of ROIV shares in the open market
  4. Aug 20, 2026InsiderDirector sold ~$653K of ROIV shares in the open market
  5. Aug 21, 2026InsiderDirector sold ~$5.28M of ROIV shares in the open market
  6. Aug 28, 2026Insider · 1 personInsiders: 2 sales (~$7.2M)
  7. Sep 8, 2026InsiderDirector sold ~$798K of ROIV shares in the open market
  8. Sep 15, 2026Insider · 2 peopleInsiders: 4 sales (~$399K)
  9. Sep 30, 2026InsiderCEO sold ~$7.32M of ROIV shares in the open market
  10. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$641K)
  11. Oct 20, 2026Insider · 1 personInsiders: 2 sales (~$7.0M)
  12. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 8.2%
  13. Oct 28, 2026InsiderCEO sold ~$7.32M of ROIV shares in the open market
  14. Nov 3, 2026InsiderCEO sold ~$7.26M of ROIV shares in the open market
  15. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 11.8%
  16. Nov 9, 2026Company filing · Form 8-K · ResultsReported its results
  17. Nov 10, 2026Insider · 2 peopleInsiders: 3 sales (~$12.8M)
  18. Nov 11, 2026Insider · 1 personInsiders: 3 sales (~$7.3M)
  19. Nov 16, 2026Insider · 3 peopleInsiders: 12 sales (~$91.5M)
  20. Nov 17, 2026Insider · 3 peopleInsiders: 9 sales (~$69.1M)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 55 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

How this filing works

Explore the data

Common questions

What does this filing report about Roivant Sciences (ROIV) stock?

Weiss Asset Management LP opened a new position in Roivant Sciences, per its Q2 2026 13F. 2.54M shares reported, 1.2% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 14, 2026.

What stands out in this filing?

A new position in Q2 2026: 2,542,652 shares, none in the manager's Q1 2026 filing. Reported at $90M, 1.20% of the portfolio value in this 13F filing. 13 other tracked managers reported the same kind of change for Q2 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Roivant Sciences recently?

For Roivant Sciences, OQRO holds 55 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.

Does this mean ROIV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data